Serum levels of chemokines in adolescents with major depression treated with fluoxetine-Reference-Cited by-同舟云学术

Serum levels of chemokines in adolescents with major depression treated with fluoxetine

Published:2020-08-19 Issue:8 Volume:10 Page:175-186
ISSN:2220-3206
Container-title:World Journal of Psychiatry
language:
Short-container-title:WJP

Author:

Peña Francisco Rafael de la,Cruz-Fuentes Carlos,Palacios Lino,Girón-Pérez Manuel Iván,Medina-Rivero Emilio,Ponce-Regalado Maria Dolores,Alvarez-Herrera Samantha,Pérez-Sánchez Gilberto,Becerril-Villanueva Enrique,Maldonado-García José Luis,Jiménez-Martínez María C,Pavón Lenin

Publisher

Baishideng Publishing Group Inc.

Reference46 articles.

1. WHO. Depression. 2019 [cited 5 December 2019]. Available from: https://www.who.int/en/news-room/fact-sheets/detail/depression

2. 10-Year Research Update Review: The Epidemiology of Child and Adolescent Psychiatric Disorders: II. Developmental Epidemiology

3. Evaluation of a school-based depression prevention program among adolescents with elevated depressive symptoms: study protocol of a randomized controlled trial

4. The Relationship of Depression and Stressors to Immunological Assays: A Meta-Analytic Review

5. A Meta-Analysis of Cytokines in Major Depression

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteomic profiles of cytokines and chemokines in moderate to severe depression: Implications for comorbidities and biomarker discovery;Brain, Behavior, & Immunity - Health;2024-03

2. Decreased IL-4 is the risk factor of depression in patients with Takayasu arteritis;Frontiers in Medicine;2024-02-15

3. Biomarkers associated with treatment outcome in young people with depression: A systematic review;Neuroscience Applied;2024

4. Upregulation of S100A8 in peripheral blood mononuclear cells from patients with depression treated with SSRIs: a pilot study;Proteome Science;2023-12-04

5. Altered serum TNF-α and MCP-4 levels are associated with the pathophysiology of major depressive disorder: A case-control study results;PLOS ONE;2023-11-15